Clinical Trial Update: Identification of New FTLD Genes

View source ↗

Summary

Clinical trial update focusing on identifying new genetic contributors to frontotemporal dementia (FTLD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Frontotemporal Lobar Degeneration | Status: UNKNOWN